Alan Ramos-Mayo

Dr. Alan Ramos-Mayo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2024 in Diseases
Verified
Journal Article
Open access
PDF file
JMJavier Melchor-Ruan
Javier Melchor-Ruan
LSLuis Santiago-Ruiz
Luis Santiago-Ruiz
BOBlanca Olivia Murillo Ortiz
Blanca Olivia Murillo Ortiz
SRSamuel Rivera Rivera
Samuel Rivera Rivera
YLYelda A. Leal-Herrera
Yelda A. Leal-Herrera
DZDANIEL Zamora-Valdés
DANIEL Zamora-Valdés
Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, affecting both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information was extracted retrospectively from the medical records of patients with HCC initially treated (2015–2022) at institutions participating in a national survey across the country. The male-to-female ratio was calculated at the national and regional levels, and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4 ± 11.9 years and 20% were diagnosed at ≥75 years. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions, to 2.1:1 in the western region. The proportion of cirrhosis was similar between the sexes; however, the etiology of cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects both men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.

29 November 2023 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JCJose Carrillo
Jose Carrillo
LCLiliana C. Carrillo
Liliana C. Carrillo
MRMargarita C. Ramírez-Ortega
Margarita C. Ramírez-Ortega
IPIrlanda Pacheco-Bravo
Irlanda Pacheco-Bravo
ARAlan Ramos-Mayo
Alan Ramos-Mayo
LOLuis F. Oñate-Ocaña
Luis F. Oñate-Ocaña

30 May 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
JMJavier Melchor-Ruan
Javier Melchor-Ruan
LSLuis Santiago-Ruiz
Luis Santiago-Ruiz
BOBlanca Olivia Murillo Ortiz
Blanca Olivia Murillo Ortiz
SRSamuel Rivera Rivera
Samuel Rivera Rivera
YHYelda A Leal Herrera
Yelda A Leal Herrera
DZDANIEL Zamora-Valdés
DANIEL Zamora-Valdés
Liver cancer is the fourth leading cause of cancer-related death worldwide. In Mexico, there is a high burden of liver cancer mortality in rural states, which affects both women and men equally. Thus, we aimed to describe the demographic and clinical characteristics of hepatocellular cancer (HCC) by sex in Mexico. Demographic and clinical information were extracted retrospectively from the medical records of patients with HCC initially treated (2015-2022) at participating institutions of a national survey across the country. The male-to-female ratio was calculated at the national and regional levels and the results were stratified by sex. Among 697 HCC patients, the age at diagnosis was 65.4±11.9y and 20% were diagnosed at ≥75y. The male-to-female ratio was 1.4:1, ranging from 1:1 in the northwestern and southwestern regions to 2.1:1 in the western region. The proportion of cirrhosis was similar between sexes; however, the etiologies for cirrhosis differed: cryptogenic cirrhosis was higher in women and alcohol consumption was higher in men. Men had a higher proportion of advanced HCC, poor/undifferentiated tumors, and ≥4 nodules than women. HCC in the Mexican population affects men and women at a 1.4:1 male-to-female ratio. This unique proportion by sex could be explained by the differences in the prevalence of risk factors across our heterogeneous country.